These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28106103)

  • 1. SOX2 and Rb1 in esophageal small-cell carcinoma: their possible involvement in pathogenesis.
    Ishida H; Kasajima A; Kamei T; Miura T; Oka N; Yazdani S; Ozawa Y; Fujishima F; Sakurada A; Nakamura Y; Tanaka Y; Kurosumi M; Ishikawa Y; Okada Y; Ohuchi N; Sasano H
    Mod Pathol; 2017 May; 30(5):660-671. PubMed ID: 28106103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16 in highly malignant esophageal carcinomas: the correlation with clinicopathological factors and human papillomavirus infection.
    Ishida H; Kasajima A; Fujishima F; Akaishi R; Ueki S; Yamazaki Y; Onodera Y; Gao X; Okamoto H; Taniyama Y; Kamei T; Sasano H
    Virchows Arch; 2021 Feb; 478(2):219-229. PubMed ID: 32556556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes.
    Li R; Yang Z; Shao F; Cheng H; Wen Y; Sun S; Guo W; Li Z; Zhang F; Xue L; Bi N; Wang J; Sun Y; Li Y; Tan F; Xue Q; Gao S; Shi S; Gao Y; He J
    Nat Commun; 2021 Jun; 12(1):3785. PubMed ID: 34145257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract.
    Long KB; Hornick JL
    Hum Pathol; 2009 Dec; 40(12):1768-73. PubMed ID: 19716157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer.
    Wilbertz T; Wagner P; Petersen K; Stiedl AC; Scheble VJ; Maier S; Reischl M; Mikut R; Altorki NK; Moch H; Fend F; Staebler A; Bass AJ; Meyerson M; Rubin MA; Soltermann A; Lengerke C; Perner S
    Mod Pathol; 2011 Jul; 24(7):944-53. PubMed ID: 21460799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas.
    Sholl LM; Long KB; Hornick JL
    Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):55-61. PubMed ID: 19661786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.
    Bass AJ; Watanabe H; Mermel CH; Yu S; Perner S; Verhaak RG; Kim SY; Wardwell L; Tamayo P; Gat-Viks I; Ramos AH; Woo MS; Weir BA; Getz G; Beroukhim R; O'Kelly M; Dutt A; Rozenblatt-Rosen O; Dziunycz P; Komisarof J; Chirieac LR; Lafargue CJ; Scheble V; Wilbertz T; Ma C; Rao S; Nakagawa H; Stairs DB; Lin L; Giordano TJ; Wagner P; Minna JD; Gazdar AF; Zhu CQ; Brose MS; Cecconello I; Ribeiro U; Marie SK; Dahl O; Shivdasani RA; Tsao MS; Rubin MA; Wong KK; Regev A; Hahn WC; Beer DG; Rustgi AK; Meyerson M
    Nat Genet; 2009 Nov; 41(11):1238-42. PubMed ID: 19801978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma.
    Wang Q; He W; Lu C; Wang Z; Wang J; Giercksky KE; Nesland JM; Suo Z
    Anticancer Res; 2009 Apr; 29(4):1233-41. PubMed ID: 19414369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma.
    Shahryari A; Rafiee MR; Fouani Y; Oliae NA; Samaei NM; Shafiee M; Semnani S; Vasei M; Mowla SJ
    Stem Cells; 2014 Jan; 32(1):126-34. PubMed ID: 24105929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of the SOX2 protein in the development of esophagus and esophageal squamous cell carcinoma, and pharmacological target for therapy.
    Zhang J; Wang Z; Zhao H; Wei Y; Zhou Y; Zhang S; Zhao J; Li X; Lin Y; Liu K
    Biomed Pharmacother; 2023 Jul; 163():114764. PubMed ID: 37100016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX2-silenced squamous cell carcinoma: a highly malignant form of esophageal cancer with SOX2 promoter hypermethylation.
    Maehara R; Fujikura K; Takeuchi K; Akita M; Abe-Suzuki S; Karbanová J; Corbeil D; Itoh T; Kakeji Y; Zen Y
    Mod Pathol; 2018 Jan; 31(1):83-92. PubMed ID: 28862264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the RB1-SOX2 axis constitutes a tool for viral status determination and diagnosis in Merkel cell carcinoma.
    Thanguturi S; Tallet A; Miquelestorena-Standley E; Coco C; Le Corre Y; Hainaut-Wierzbicka E; Blom A; Saiag P; Beneton N; Bens G; Zaragoza J; Nardin C; Aubin F; Dinulescu M; Machet MC; Houben R; Schrama D; Collin C; Fromont G; Jullie ML; Macagno N; Gaboriaud P; Berthon P; Touzé A; Guyétant S; Samimi M; Kervarrec T
    Virchows Arch; 2022 Jun; 480(6):1239-1254. PubMed ID: 35412101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Utility of ERBB4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal Oncocytoma.
    Sun T; Hutchinson L; Zhou AG; Liu Q; Cosar EF; St Cyr M; Ninteau N; Dresser K; Cheng L; Jiang Z; Cornejo KM
    Int J Surg Pathol; 2020 May; 28(3):259-264. PubMed ID: 31640438
    [No Abstract]   [Full Text] [Related]  

  • 14. High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.
    Chuang WY; Chang YS; Chao YK; Yeh CJ; Liu YH; Tseng CK; Chang HK; Wan YL; Hsueh C
    Int J Clin Exp Pathol; 2015; 8(8):9248-55. PubMed ID: 26464673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis for cell proliferation-related protein expression in small cell carcinoma of the esophagus; a comparative study with small cell carcinoma of the lung and squamous cell carcinoma of the esophagus.
    Okudela K; Ito T; Kameda Y; Nakamura N; Kitamura H
    Histol Histopathol; 1999 Apr; 14(2):479-85. PubMed ID: 10212809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podoplanin and SOX2 expression in esophageal squamous cell carcinoma after neoadjuvant chemo-radiotherapy.
    Saigusa S; Mohri Y; Ohi M; Toiyama Y; Ishino Y; Okugawa Y; Tanaka K; Inoue Y; Kusunoki M
    Oncol Rep; 2011 Nov; 26(5):1069-74. PubMed ID: 21811761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of Rb1, cyclin D1 and p16 immunohistochemistry expression to distinguish lung small-cell carcinoma and large-cell neuroendocrine carcinoma.
    Papaxoinis G; Bille A; McLean E; Nonaka D
    Histopathology; 2022 Aug; 81(2):205-214. PubMed ID: 35544410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic stem cell markers Sox-2 and OCT4 expression and their correlation with WNT signal pathway in cervical squamous cell carcinoma.
    Ji J; Wei X; Wang Y
    Int J Clin Exp Pathol; 2014; 7(5):2470-6. PubMed ID: 24966958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker.
    Turner JR; Odze RD; Crum CP; Resnick MB
    Hum Pathol; 1997 Jun; 28(6):740-4. PubMed ID: 9191010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox2 induces tumorigenesis and angiogenesis of early-stage esophageal squamous cell carcinoma through secretion of Suprabasin.
    Takahashi K; Asano N; Imatani A; Kondo Y; Saito M; Takeuchi A; Jin X; Saito M; Hatta W; Asanuma K; Uno K; Koike T; Masamune A
    Carcinogenesis; 2020 Nov; 41(11):1543-1552. PubMed ID: 32055838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.